Drug intelligence / Profile preview

Mag2

Development stage
Unknown
Lead developer
The Cooper Companies
Modality
Small Molecules
Administration
Oral
01

Overview

Mag2 is a range of magnesium-based products developed by Cooperation Pharmaceutique Francaise (Cooper Consumer Health). The brand encompasses both over-the-counter (OTC) medications and dietary supplements designed to address magnesium deficiency and its associated symptoms, such as nervousness, irritability, mild anxiety, temporary fatigue, and minor sleep disturbances. The core pharmaceutical formulation, often provided as an oral solution in ampoules, typically contains magnesium pidolate. Other variants, such as Mag2 24h, utilize a combination of magnesium carbonate and magnesium oxide to provide a sustained release of elemental magnesium over a 24-hour period. Many products in the Mag2 line also include Vitamin B6 (pyridoxine) to enhance the intestinal absorption of magnesium and support normal psychological and nervous system function. Mag2 is a leading brand in the French consumer health market and is available in various dosage forms including tablets, sachets, and gummies.

Brand names
Mag2Mag-2Mag 2Mag2 24hMag-2 24hMag 2 24hMag2 CrampMag-2 CrampMag 2 CrampMag2 SommeilMag-2 SommeilMag 2 SommeilMag2 GummiesMag-2 GummiesMag 2 Gummies
Other names
magnesium pidolatemagnesium carbonatemagnesium oxidemagnesium citrate
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on Mag2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mag2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call